Curis
CRIS
#10197
Rank
S$22.71 M
Marketcap
S$1.76
Share price
0.37%
Change (1 day)
-68.35%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): S-$4.87

According to Curis's latest financial reports the company's current EPS (TTM) is S-$4.76. In 2024 the company made an earnings per share (EPS) of S-$9.12 an increase over its 2023 EPS that were of S-$11.70.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.87-46.54%
2024S-$9.12-22.06%
2023S-$11.70-26.25%
2022S-$15.8622.3%
2021S-$12.97-25.37%
2020S-$17.38-30.93%
2019S-$25.16-2.02%
2018S-$25.68
2016S-$58.36-10%
2015S-$64.84138.1%
2014S-$27.2340%
2013S-$19.45-25%
2012S-$25.9466.67%
2011S-$15.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
S$3.09-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.83-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.47-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$4.38-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.23-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.85-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$14.58 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA